ANTONIO JOSÉ
CARUZ ARCOS
CATEDRATICO DE UNIVERSIDAD
Karin
Neukam
Publicacións nas que colabora con Karin Neukam (19)
2014
-
A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers
Liver International, Vol. 34, Núm. 4, pp. 558-566
-
Association of low-density lipoprotein receptor genotypes with hepatitis C viral load
Genes and Immunity, Vol. 15, Núm. 1, pp. 16-24
-
IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against hepatitis C virus genotype 1 or 4 in Caucasians
PLoS ONE, Vol. 9, Núm. 4
2013
-
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 4, pp. 915-921
-
Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV
Infection, Vol. 41, Núm. 1, pp. 21-26
-
Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 32, Núm. 11, pp. 1427-1435
-
Pegylated interferon plus ribavirin is suboptimal inIL28B CC carriers without rapid response
Journal of Infection, Vol. 67, Núm. 1, pp. 59-64
-
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection
AIDS, Vol. 27, Núm. 17, pp. 2715-2724
2012
-
Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 1, pp. 202-205
-
Differences in virological response to peginterferon-a plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b
Journal of Acquired Immune Deficiency Syndromes, Vol. 60, Núm. 2, pp. 117-123
-
LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients
AIDS, Vol. 26, Núm. 8, pp. 1009-1015
-
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
Journal of Hepatology, Vol. 56, Núm. 4, pp. 788-794
2011
-
Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype
HIV Medicine, Vol. 12, Núm. 8, pp. 487-493
-
Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapse
AIDS, Vol. 25, Núm. 8, pp. 1131-1133
-
Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy
Journal of Infectious Diseases, Vol. 203, Núm. 11, pp. 1629-1636
-
Influence of the combination of low-density lipoprotein receptor and interleukin 28B genotypes on lipid plasma levels in HIV/hepatitis C-coinfected patients
Journal of Acquired Immune Deficiency Syndromes
-
Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 25, Núm. 11, pp. 1415-1420
2010
-
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
Clinical Infectious Diseases, Vol. 51, Núm. 10, pp. 1209-1216
-
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 51, Núm. 7, pp. 788-795